Related Experiment Video
Updated: Nov 15, 2025
07:22
Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
Published on: September 1, 2023
3.1K
iPSC technology-based regenerative medicine for kidney diseases
1Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. osafu@cira.kyoto-u.ac.jp.
Clinical and Experimental Nephrology
|March 3, 2021
Summary
Human-induced pluripotent stem cells (hiPSCs) offer new hope for kidney disease treatment through regenerative medicine. Researchers are developing hiPSC-based therapies for kidney regeneration, acute kidney injury, and disease modeling.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Nephrology
Background:
- Limited curative treatments for kidney diseases necessitate novel therapeutic approaches.
- Human-induced pluripotent stem cells (hiPSCs) show significant promise for kidney regeneration.
- Understanding kidney developmental biology is crucial for guiding hiPSC differentiation.
Purpose of the Study:
- To review the current advancements in kidney regeneration using hiPSC technology.
- To explore the potential of hiPSC-derived cells and tissues for therapeutic applications in kidney diseases.
- To discuss future perspectives in kidney regenerative medicine and iPSC-based research.
Main Methods:
- Directed differentiation of hiPSCs into nephron progenitor cells (NPCs) and ureteric bud (UB) progenitors.
- Generation of kidney organoids and human kidney tissues from hiPSC-derived progenitors.
- In vivo studies involving transplantation of hiPSC-derived kidney tissues and cell therapy for acute kidney injury (AKI) in mice.
Main Results:
- Established protocols for differentiating hiPSCs into NPCs and UB, enabling the generation of nephron and collecting duct organoids.
- Successfully generated interconnected human kidney tissues from hiPSC-derived progenitors, which become vascularized upon transplantation.
- Demonstrated therapeutic potential of hiPSC-derived NPCs in ameliorating AKI in mice and developing disease models for conditions like ADPKD.
Conclusions:
- hiPSC technology is a powerful tool for kidney regeneration, offering potential for transplantation, cell therapy, disease modeling, and drug discovery.
- Further research into hiPSC-based strategies holds promise for addressing unmet needs in various kidney diseases, including renal anemia.
- The integration of developmental biology principles with iPSC technology is paving the way for innovative regenerative medicine approaches for kidney disorders.
Related Concept Videos
01:22iPS Cell Differentiation
2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
01:13Induced Pluripotent Stem Cells
25.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
25.3K
01:06Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K
01:21EPS and iPS Cells in Disease Research
3.1K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K
01:28Kidney Transplant I: Introduction
147
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
147
01:21Stem Cell Therapy for Tissue Regeneration
4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K